.

.
kim kardashian gives birth to baby
Showing posts with label abramson-cancer-center. Show all posts
Showing posts with label abramson-cancer-center. Show all posts

Penn's Abramson Cancer Center Hailed as ‘Exceptional’ by NCI

Penn's Abramson Cancer Center has been rated "exceptional" by the National Cancer Institute. During a competitive, peer-review process that evaluates applications according to merit, the Abramson Cancer Center was recognized for its:
  • High quality of cancer research
  • State-of-the-art research and patient-care facilities\
  • Experienced scientific leadership
  • Level of collaboration and translation of science to innovative cancer care
The Abramson Cancer Center’s commitment to research provides cancer patients with access to more clinical trials and the most advanced treatment options.

Ranked by U.S.News & World Report as best for cancer care in Pennsylvania, New Jersey, and Delaware, and among the top in the nation, the Abramson Cancer Center has more ways to save patients’ lives.

Meet Chi Van Dang, MD, PhD, Director of Penn’s Abramson Cancer Center

Chi Van Dang, MD, PhD, has joined Penn Medicine as director of Penn’s Abramson Cancer Center and director of the Abramson Family Cancer Research Institute. Over the course of his illustrious career, Dr. Dang has distinguished himself as a highly effective clinical researcher as well as a preeminent scholar and educator in the fields of cancer cell biology, molecular biology and genetics.

“I feel very privileged and excited for the opportunity to lead the Abramson Cancer Center into an era of innovative personalized cancer care through the establishment of disease-specific translational centers of excellence,” says Dr. Dang.

Screening for Testicular and Prostate Cancer

Testicular CancerDid you know that testicular cancer and prostate cancer are not only the most common types of cancer in men, but are highly curable when found and treated early? Luckily, both of these cancer types can often be detected early in their development through simple tests, allowing doctors to begin treatment quickly.

Screening for Testicular Cancer
Most women know how to perform a monthly breast self-exam to detect a cancerous lump. But did you know men can perform a testicular self-exam using a simple, three step exam performed at home?

Get more information and tips on how to perform a self-exam.
 
Should you be Screened for Prostate Cancer?
All men aged 50 or older are encouraged to get a screening for prostate cancer, but men at risk are especially encouraged. High risk includes:
  • Men aged 45 who are African American
  • Men with a father or brother who had prostate cancer before the age of 65
Screenings consist of a physical exam and a prostate specific antigen (PSA) test - a simple blood test that your doctor can perform to determine your PSA levels. A high PSA level can indicate a problem with your prostate, which may or not be prostate cancer.

Diagnosed with Cancer?
If either of these tests lead to a cancer diagnosis, understanding your options is critical. The Abramson Cancer Center offers patients a wide array of the most advanced options available, including minimally invasive and robotic surgical options, and proton therapy, the most advanced form of radiation therapy available.

Learn more about the Penn Urology team
or schedule an appointment by calling 800-789-PENN.

More Ways to Save Your Life: CyberKnife® at Pennsylvania Hospital

CyberKnife® delivers high dose radiation to tumors with extreme precision. With a dynamic linear accelerator and sophisticated image-guided technology, CyberKnife treats cancerous and non-cancerous tumors primarily in the prostate, lung, spine, brain, liver, pancreas and kidney. It can also be used for patients who have tumors that cannot be treated with conventional surgery or lesions that were previously treated with radiation therapy.

Penn Medicine is pleased to offer every form of advanced radiation therapy, including CyberKnife, Gamma Knife® and proton therapy, which allows Penn physicians to determine the most effective treatment with the least side effects for each patient. Patients can be evaluated for CyberKnife and other radiation therapy treatment options at Pennsylvania Hospital, the Ruth and Raymond Perelman Center for Advanced Medicine and locations throughout the Philadelphia region through the Penn Radiation Oncology Network.

Learn more about the benefits of CyberKnife
Watch Penn Radiation Oncology’s Patient Guide Video
Find out more about Penn Radiation Oncology Network

Support Cancer Survivorship: Take the LIVESTRONG™ Challenge

Penn's Abramson Cancer Center and The Cancer Center at The Children's Hospital of Philadelphia are proud to support the LIVESTRONG™ Challenge on August 20 and 21, 2011 at Montgomery County Community College in Blue Bell.

The LIVESTRONG Challenge is a two-day event that benefits Penn’s Living Well after Cancer™ Program. On Saturday, August 20, there is a 5K and 10K run/walk and health and wellness expo. On Sunday, August 21, there is a multi-distance bike ride with 10-, 20, 45-, 70- and 100-mile options through the Pennsylvania countryside.

Penn’s nationally recognized survivorship program is a member of the LIVESTRONG™ Survivorship Center of Excellence Network. This status reflects Penn’s excellence in providing clinical care and education to adult and childhood cancer survivors.

Join Team Penn/CHOP
Watch footage from Lance Armstrong’s visit to Penn
Learn more about Penn’s Living Well After Cancer™ Program

Proton Therapy for Prostate Cancer: A Patient’s Story

When Frank McKee was diagnosed with prostate cancer, he wanted to find the best treatment to fight the disease. After extensively researching treatment options, he finally chose proton therapy, the world’s most advanced form of radiation therapy.


“I wanted to treat the cancer and I wanted to be done with it in a way that had a minimum amount of side effects and affected my life the least,” McKee said. 

Proton therapy offers a variety of benefits to patients with prostate cancer. These include:
  • Reduced radiation to normal, healthy tissues
  • Decreased chance of side effects, complications and toxicity
  • Maximum radiation dose administered directly to the tumor
  • Fewer daily treatments, as deemed appropriate 
  • Ability to re-treat tumors
“My life has been very, very full in the last year and a half since I finished treatment,” said McKee. “There are times I totally forget I had prostate cancer. And that’s a good thing.”

Empowering Cancer Survivors

More people are surviving cancer than ever before thanks in part to advances in diagnosis and treatment. Today, there are more than 13 million cancer survivors in the United States. The LIVESTRONG Care Plan™, powered by Penn Medicine's OncoLink, is a powerful tool for cancer survivors. The plan provides guidance to survivors, their families and their healthcare providers on managing the medical and psychosocial issues that may arise following cancer treatment.

After surviving cancer, many patients and their loved ones want to learn more about cancer risk. The Mariann and Robert MacDonald Women’s Cancer Risk Evaluation Center and Penn’s Gastrointestinal (GI) Risk Evaluation Program provide patients with information about genetic risk, specialized screenings and personalized plans for reducing cancer risk. The comprehensive programs also offer opportunities to participate in clinical trials to advance the study of inherited risk of cancer.

Create a LIVESTRONG Care Plan powered by Penn Medicine's OncoLink
Mariann and Robert MacDonald Women’s Cancer Risk Evaluation Center
Penn’s Gastrointestinal (GI) Risk Evaluation Program

Penn’s Basser Research Center: Only Center in the World Dedicated to BRCA Research


The Basser Research Center at Penn Medicine was created with the assistance of a $25 million transformational gift from Penn alumni, Mindy and Jon Gray. As part of Penn's Abramson Cancer Center, the center is the first of its kind in the world dedicated to researching BRCA. BRCA1 and BRCA2 genes are gene mutations associated with an increased risk of developing breast and ovarian cancer.

The center focuses on every stage of the diagnosis including:
  • Communication
  • Outreach and risk assessment
  • Prevention
  • Early detection
  • Treatment
  • Survivorship
Led by Executive Director Susan M. Domchek, MD, the center supports research with a focus on interdisciplinary work and seeks to accelerate the pace of translational research. Starting with a team of eight revolutionary researchers and physicians, the Basser Research Center is dedicated to better understanding the development of cancer, creating less invasive interventions for prevention and treatment and ultimately, saving lives. 

Proton Therapy for Lung Cancer: The Most Advanced Radiation Therapy Available

Lung cancer is the nation’s leading cause of cancer death for both men and women. Penn Medicine offers a comprehensive team approach for treating lung cancer, including proton therapy, the most advanced form of radiation therapy available today. Radiation oncologists at the Roberts Proton Therapy Center use high-speed protons to create a particle beam that delivers precise radiation directly to the tumor. Proton therapy allows patients to receive higher, more targeted doses of radiation, which helps preserve surrounding healthy tissue. For patients, this means fewer side effects.

Patient Story: Proton Therapy for Non-Small Cell Lung Cancer


Proton Therapy Helped Me Share Moments with My Grandchildren
Kathy Brandt was diagnosed with non-small cell lung cancer in 2011 at her local hospital. After much research, and a recommendation from her brother-in-law, who is a physician, Kathy chose Penn Medicine for her lung cancer treatment, which included proton therapy. Today, Kathy is cancer free. 

You hear the word “cancer” and it's truly terrifying.

It was basically just a checkup with my pulmonologist because I have emphysema. He sent me for a chest X-ray and that is when they found the tumor in my lung. It was a terrifying time and thankfully I had strong family surrounding me - strong family helping me make decisions about what kind of treatment I should have. After that initial diagnosis, when you feel like you have been hit with a ton of bricks, then the decision needs to be made where you are going to seek treatment. My brother-in-law, who is a physician, along with my pulmonologist suggested I go to Penn Medicine for treatment.

Penn Medicine was a wonderful choice for us. They used a team approach.  I saw an oncologist, I saw a surgeon, and the radiologist is all located at Penn Medicine.  It was very comforting to know that all these people are just working to take care of you and to make you better.

I was diagnosed with non-small cell lung cancer at the end of June.  My surgery was the beginning of August and chemo started in September. It was finished in November.  I started proton therapy in December, which lasted for 4 weeks.

Deciding to Have Proton Therapy at Penn
I decided to go with the proton radiation because of the cancer’s proximity to my heart and spine. I chose proton therapy because I knew it would be more precise and would have less side effects and that was very important to me.

The Proton Therapy Experience
Every day for 5 weeks, I would leave work, come home, and my husband would take me to Penn for proton therapy. After the treatment, we’d go home and I’d spend time with my grandchildren and their parents, who were living with us at the time. My granddaughter was about 3 months old at the time. And I would take her, feed her, and just spend time with the people that meant the most to me.

I really felt wonderful. I continued to work the whole time I had proton therapy – I never missed a day of work, actually. I was a bit more tired than usual, but that was really the only side effect I felt.

When I completed proton therapy, I rang the bell.  Everybody in the waiting room clapped, and we went home and I think I had a very big glass of wine after treatment was finished.

After Proton Therapy
Today, I don’t sweat the small stuff.

I would tell anyone to feel very comfortable going to Penn Medicine, and I would tell anyone to also feel very comfortable in choosing proton therapy simply because of the fewer side effects and its extreme precision.  I would recommend Penn Medicine wholeheartedly.  I cannot say enough good things about my experience.

Learn More About Proton Therapy at Penn Medicine
Proton therapy is a non-invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy the DNA of cancer cells killing them and preventing them from multiplying.

Unlike conventional radiation that can affect surrounding healthy tissue as it enters the body and targets the tumor, proton therapy’s precise, high dose of radiation is extremely targeted. This targeted precision causes less damage to healthy, surrounding tissue.

Watch the full video of Kathy's experience.

Learn more about proton therapy, or schedule a consultation with a radiation oncologist at Penn Medicine. 

Abramson Cancer Center at Penn Medicine Valley Forge is Now Open


Expert Cancer Care is Now Just Around the Corner 

When faced with a cancer diagnosis, patients and their families deserve the best. As world-renowned experts in cancer care, Penn physicians offer the most advanced treatment options, groundbreaking research and the compassionate care patients and families need before, during and after a cancer diagnosis.

Penn Medicine is pleased to offer residents of the Valley Forge community that same level of care closer to home at the new Abramson Cancer Center at Penn Medicine Valley Forge.

Designed to offer patients the best experience possible, this brand new two-floor and 18-exam room facility features a broad range of cancer services including:
  • Office consultations
  • Second opinions
  • Chemotherapy treatments in a newly designed infusion suite
  • Radiation therapy
  • Laboratory services
  • Access to the latest clinical trials, research, and cutting edge treatments like proton therapy — the most advanced and precise form of radiation therapy in the world

Learn more about the new Abramson Cancer Center at Penn Medicine